No Result

View All Result

No products in the cart.

2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑

Home StudyGraphics

#VisualAbstract: Treatment with semaglutide reduced body mass index in adolescents with obesity

byZain Cheema

May 2, 2023

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Treatment with semaglutide reduced body mass index in adolescents with obesity

#VisualAbstract: Selective decontamination of digestive tract does not result in reduction of in-hospital mortality

RelatedReports

Increasing maternal BMI linked to higher risk of cerebral palsy

Endocrinology

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

August 31, 2026

Fatty liver disease may independently predict high-risk coronary disease

Cardiology

Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

August 21, 2026

Sleep duration inversely related to childhood type 2 diabetes risk makers

Endocrinology

Use of semaglutide for weight control among women of reproductive age is more common in those using hormonal contraception

July 30, 2026

Variability in interpretation of breast biopsy slides associated with low verification of atypia and ductal carcinoma in situ

Weekly Rewinds

2 Minute Medicine Rewind July 27th, 2026

July 27, 2026

No difference between warfarin or dabigatran for cognitive outcomes in geriatric populations

Casino expansion associated with decreased childhood risk of obesity

Sports betting may be associated with elevated levels of problem gambling

First-line treatment with immune checkpoint inhibitor rather than BRAF and MEK leads to improved survival

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Treatment with semaglutide reduced body mass index in adolescents with obesity

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

Use of semaglutide for weight control among women of reproductive age is more common in those using hormonal contraception

#VisualAbstract: Selective decontamination of digestive tract does not result in reduction of in-hospital mortality

No difference between warfarin or dabigatran for cognitive outcomes in geriatric populations

RelatedReports

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

Use of semaglutide for weight control among women of reproductive age is more common in those using hormonal contraception

2 Minute Medicine Rewind July 27th, 2026

No difference between warfarin or dabigatran for cognitive outcomes in geriatric populations

Sports betting may be associated with elevated levels of problem gambling

First-line treatment with immune checkpoint inhibitor rather than BRAF and MEK leads to improved survival

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits

#VisualAbstract: Treatment with semaglutide reduced body mass index in adolescents with obesity

RELATED REPORTS

#VisualAbstract: Selective decontamination of digestive tract does not result in reduction of in-hospital mortality

No difference between warfarin or dabigatran for cognitive outcomes in geriatric populations

RelatedReports

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits